Phenotypic and molecular characterization of the exon 13-15 duplication in LDLR: Implications for familial hypercholesterolemia.

IF 4.6 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Diego Abarzúa, Claudia Radojkovic, Santiago Quintana, Catalina Martínez, Natalia Barriga, Rodrigo Alonso, Enrique Guzman, Carlos Felipe Burgos, Andrea Sánchez
{"title":"Phenotypic and molecular characterization of the exon 13-15 duplication in LDLR: Implications for familial hypercholesterolemia.","authors":"Diego Abarzúa, Claudia Radojkovic, Santiago Quintana, Catalina Martínez, Natalia Barriga, Rodrigo Alonso, Enrique Guzman, Carlos Felipe Burgos, Andrea Sánchez","doi":"10.1016/j.jacl.2025.06.023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Familial hypercholesterolemia (FH) is an inherited disorder characterized by elevated levels of low-density lipoprotein (LDL) cholesterol, significantly increasing the risk of premature cardiovascular disease. Major rearrangements were among the first mutations identified in the low-density lipoprotein receptor (LDLR) gene and currently comprise approximately 10% of FH-causing variants. One of them is the exon13_15dup. However, the impact on the structure and function of the LDLR is poorly understood.</p><p><strong>Objective: </strong>To determine the structural and functional impact of the exon13_15dup variant in the LDLR gene in FH patients.</p><p><strong>Methods: </strong>The RNA extracted from CD14+ macrophage differentiation was obtained from non-consanguineous index cases carrying this mutation. Polymerase chain reaction and Sanger evaluated the junction sequence of the mutation sequenced. The obtained sequences were used to construct in silico models and perform molecular dynamics assays.</p><p><strong>Results: </strong>The exon13_15dup variant resulted in substantial structural alterations within the LDLR, producing a truncated protein lacking both the transmembrane and cytoplasmic domains.</p><p><strong>Conclusions: </strong>The structural changes caused by the exon13_15dup variant significantly impair the functionality of the LDLR protein, contributing to the clinical phenotype observed in patients with FH.</p>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":" ","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jacl.2025.06.023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Familial hypercholesterolemia (FH) is an inherited disorder characterized by elevated levels of low-density lipoprotein (LDL) cholesterol, significantly increasing the risk of premature cardiovascular disease. Major rearrangements were among the first mutations identified in the low-density lipoprotein receptor (LDLR) gene and currently comprise approximately 10% of FH-causing variants. One of them is the exon13_15dup. However, the impact on the structure and function of the LDLR is poorly understood.

Objective: To determine the structural and functional impact of the exon13_15dup variant in the LDLR gene in FH patients.

Methods: The RNA extracted from CD14+ macrophage differentiation was obtained from non-consanguineous index cases carrying this mutation. Polymerase chain reaction and Sanger evaluated the junction sequence of the mutation sequenced. The obtained sequences were used to construct in silico models and perform molecular dynamics assays.

Results: The exon13_15dup variant resulted in substantial structural alterations within the LDLR, producing a truncated protein lacking both the transmembrane and cytoplasmic domains.

Conclusions: The structural changes caused by the exon13_15dup variant significantly impair the functionality of the LDLR protein, contributing to the clinical phenotype observed in patients with FH.

LDLR外显子13-15重复的表型和分子特征:对家族性高胆固醇血症的影响
背景:家族性高胆固醇血症(FH)是一种以低密度脂蛋白(LDL)胆固醇水平升高为特征的遗传性疾病,显著增加早发心血管疾病的风险。主要的重排是在低密度脂蛋白受体(LDLR)基因中发现的第一批突变,目前约占fh引起变异的10%。其中一个是外显子13_15dup。然而,对LDLR结构和功能的影响了解甚少。目的:探讨FH患者LDLR基因外显子13_15dup变异对其结构和功能的影响。方法:从携带该突变的非近亲指数病例中提取CD14+巨噬细胞分化的RNA。聚合酶链反应和Sanger评价了突变序列的连接序列。获得的序列用于构建硅模型并进行分子动力学分析。结果:外显子13_15dup变异导致LDLR内部发生实质性的结构改变,产生缺乏跨膜和细胞质结构域的截断蛋白。结论:外显子13_15dup变异引起的结构变化显著损害了LDLR蛋白的功能,导致了FH患者观察到的临床表型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.00
自引率
6.80%
发文量
209
审稿时长
49 days
期刊介绍: Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信